vs

Side-by-side financial comparison of DIGI INTERNATIONAL INC (DGII) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

DIGI INTERNATIONAL INC is the larger business by last-quarter revenue ($122.5M vs $83.1M, roughly 1.5× PROCEPT BioRobotics Corp). DIGI INTERNATIONAL INC runs the higher net margin — 9.6% vs -38.1%, a 47.6% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 17.9%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 6.6%).

Digi International, Inc. is an American Industrial Internet of Things (IIoT) technology company based in Hopkins, Minnesota. Founded in 1985, they were best known in the early 1990s as a manufacturer of multi-line serial data serial cards for PC clones, allowing these machines to run multi-line bulletin board systems (BBSes). As this market began to wind down with the rise of the internet in the late 1990s, Digi began to concentrate on network attached devices and industrial monitoring.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

DGII vs PRCT — Head-to-Head

Bigger by revenue
DGII
DGII
1.5× larger
DGII
$122.5M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+2.3% gap
PRCT
20.2%
17.9%
DGII
Higher net margin
DGII
DGII
47.6% more per $
DGII
9.6%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
6.6%
DGII

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
DGII
DGII
PRCT
PRCT
Revenue
$122.5M
$83.1M
Net Profit
$11.7M
$-31.6M
Gross Margin
62.4%
64.9%
Operating Margin
13.3%
-4.1%
Net Margin
9.6%
-38.1%
Revenue YoY
17.9%
20.2%
Net Profit YoY
16.1%
-27.9%
EPS (diluted)
$0.31
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DGII
DGII
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$122.5M
$76.4M
Q3 25
$114.3M
$83.3M
Q2 25
$107.5M
$79.2M
Q1 25
$104.5M
$69.2M
Q4 24
$103.9M
$68.2M
Q3 24
$105.1M
$58.4M
Q2 24
$105.2M
$53.4M
Net Profit
DGII
DGII
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$11.7M
$-29.8M
Q3 25
$10.0M
$-21.4M
Q2 25
$10.2M
$-19.6M
Q1 25
$10.5M
$-24.7M
Q4 24
$10.1M
$-18.9M
Q3 24
$11.9M
$-21.0M
Q2 24
$9.7M
$-25.6M
Gross Margin
DGII
DGII
PRCT
PRCT
Q1 26
64.9%
Q4 25
62.4%
60.6%
Q3 25
63.9%
64.8%
Q2 25
63.5%
65.4%
Q1 25
62.1%
63.9%
Q4 24
62.0%
64.0%
Q3 24
61.1%
63.2%
Q2 24
59.2%
59.0%
Operating Margin
DGII
DGII
PRCT
PRCT
Q1 26
-4.1%
Q4 25
13.3%
-40.6%
Q3 25
12.5%
-27.8%
Q2 25
13.9%
-28.0%
Q1 25
13.1%
-39.7%
Q4 24
12.9%
-28.9%
Q3 24
14.2%
-38.4%
Q2 24
12.3%
-50.3%
Net Margin
DGII
DGII
PRCT
PRCT
Q1 26
-38.1%
Q4 25
9.6%
-39.1%
Q3 25
8.7%
-25.7%
Q2 25
9.5%
-24.7%
Q1 25
10.0%
-35.8%
Q4 24
9.7%
-27.6%
Q3 24
11.3%
-35.9%
Q2 24
9.2%
-48.0%
EPS (diluted)
DGII
DGII
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.31
$-0.54
Q3 25
$0.26
$-0.38
Q2 25
$0.27
$-0.35
Q1 25
$0.28
$-0.45
Q4 24
$0.27
$-0.34
Q3 24
$0.32
$-0.40
Q2 24
$0.26
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DGII
DGII
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$30.9M
$245.6M
Total DebtLower is stronger
$135.0M
$51.7M
Stockholders' EquityBook value
$649.2M
$347.7M
Total Assets
$918.4M
$487.1M
Debt / EquityLower = less leverage
0.21×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DGII
DGII
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$30.9M
$286.5M
Q3 25
$21.9M
$294.3M
Q2 25
$20.1M
$302.7M
Q1 25
$26.3M
$316.2M
Q4 24
$25.9M
$333.7M
Q3 24
$27.5M
$196.8M
Q2 24
$28.3M
$214.1M
Total Debt
DGII
DGII
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$135.0M
$51.6M
Q3 25
$159.2M
$51.6M
Q2 25
$40.1M
$51.5M
Q1 25
$70.0M
$51.5M
Q4 24
$95.0M
$51.5M
Q3 24
$123.2M
$51.4M
Q2 24
$151.6M
$51.4M
Stockholders' Equity
DGII
DGII
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$649.2M
$365.9M
Q3 25
$636.1M
$380.3M
Q2 25
$621.5M
$385.8M
Q1 25
$605.2M
$389.2M
Q4 24
$590.7M
$402.2M
Q3 24
$581.0M
$241.2M
Q2 24
$563.1M
$251.8M
Total Assets
DGII
DGII
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$918.4M
$508.1M
Q3 25
$922.6M
$511.5M
Q2 25
$770.3M
$513.1M
Q1 25
$781.0M
$519.4M
Q4 24
$796.1M
$534.0M
Q3 24
$815.1M
$374.1M
Q2 24
$820.4M
$374.4M
Debt / Equity
DGII
DGII
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.21×
0.14×
Q3 25
0.25×
0.14×
Q2 25
0.06×
0.13×
Q1 25
0.12×
0.13×
Q4 24
0.16×
0.13×
Q3 24
0.21×
0.21×
Q2 24
0.27×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DGII
DGII
PRCT
PRCT
Operating Cash FlowLast quarter
$35.6M
Free Cash FlowOCF − Capex
$35.2M
FCF MarginFCF / Revenue
28.7%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
3.04×
TTM Free Cash FlowTrailing 4 quarters
$111.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DGII
DGII
PRCT
PRCT
Q1 26
Q4 25
$35.6M
$-10.3M
Q3 25
$28.0M
$-6.6M
Q2 25
$24.0M
$-15.0M
Q1 25
$26.3M
$-17.0M
Q4 24
$29.7M
$-32.4M
Q3 24
$26.4M
$-18.8M
Q2 24
$24.9M
$-15.7M
Free Cash Flow
DGII
DGII
PRCT
PRCT
Q1 26
Q4 25
$35.2M
$-12.2M
Q3 25
$27.5M
$-9.5M
Q2 25
$22.9M
$-17.8M
Q1 25
$25.7M
$-18.8M
Q4 24
$29.1M
$-33.6M
Q3 24
$25.5M
$-19.0M
Q2 24
$24.5M
$-16.8M
FCF Margin
DGII
DGII
PRCT
PRCT
Q1 26
Q4 25
28.7%
-15.9%
Q3 25
24.1%
-11.4%
Q2 25
21.3%
-22.5%
Q1 25
24.6%
-27.2%
Q4 24
28.1%
-49.2%
Q3 24
24.3%
-32.6%
Q2 24
23.2%
-31.4%
Capex Intensity
DGII
DGII
PRCT
PRCT
Q1 26
Q4 25
0.4%
2.4%
Q3 25
0.4%
3.4%
Q2 25
0.9%
3.5%
Q1 25
0.5%
2.7%
Q4 24
0.6%
1.7%
Q3 24
0.9%
0.4%
Q2 24
0.5%
2.0%
Cash Conversion
DGII
DGII
PRCT
PRCT
Q1 26
Q4 25
3.04×
Q3 25
2.81×
Q2 25
2.34×
Q1 25
2.50×
Q4 24
2.95×
Q3 24
2.23×
Q2 24
2.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DGII
DGII

Io T Productsand Services$86.4M71%
Io T Solutions$36.1M29%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons